Nguyen, vitamin D sufficiency study: 81% lower mortality [p=0.008], 53% lower ventilation [p=0.13], and 74% higher hospital discharge [p<0.0001] https://c19p.org/nguyen3
copied to clipboard
25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients
et al., PLOS ONE, doi:10.1371/journal.pone.0268038
Retrospective 88 COVID-19 hospitalized patients and 122 controls, showing higher mortality, ventilation, and length of stay with vitamin D deficiency.
|
risk of death, 81.1% lower, OR 0.19, p = 0.008, cutoff 20ng/mL, adjusted per study, 25-OH-D3, multivariable, RR approximated with OR.
|
|
risk of mechanical ventilation, 52.8% lower, OR 0.47, p = 0.13, cutoff 20ng/mL, adjusted per study, 25-OH-D3, multivariable, RR approximated with OR.
|
|
risk of no hospital discharge, 74.0% lower, HR 0.26, p < 0.001, cutoff 20ng/mL, 25-OH-D3, Cox proportional hazards.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Nguyen et al., 5/3/2022, retrospective, USA, North America, peer-reviewed, 11 authors, study period 15 July, 2020 - 15 October, 2020.
Contact:
nguyen.nguyen2@bswhealth.org.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.